Dianthus Therapeutics (DNTH) Receivables - Other (2018 - 2024)
Historic Receivables - Other for Dianthus Therapeutics (DNTH) over the last 5 years, with Q4 2024 value amounting to $807000.0.
- Dianthus Therapeutics' Receivables - Other rose 30350.0% to $807000.0 in Q4 2024 from the same period last year, while for Dec 2024 it was $807000.0, marking a year-over-year increase of 30350.0%. This contributed to the annual value of $807000.0 for FY2024, which is 30350.0% up from last year.
- Per Dianthus Therapeutics' latest filing, its Receivables - Other stood at $807000.0 for Q4 2024, which was up 30350.0% from $1.3 million recorded in Q3 2024.
- In the past 5 years, Dianthus Therapeutics' Receivables - Other ranged from a high of $1.3 million in Q3 2024 and a low of $200000.0 during Q4 2023
- Its 3-year average for Receivables - Other is $703714.3, with a median of $800000.0 in 2024.
- Per our database at Business Quant, Dianthus Therapeutics' Receivables - Other tumbled by 7777.78% in 2023 and then skyrocketed by 30350.0% in 2024.
- Dianthus Therapeutics' Receivables - Other (Quarter) stood at $900000.0 in 2022, then crashed by 77.78% to $200000.0 in 2023, then soared by 303.5% to $807000.0 in 2024.
- Its Receivables - Other was $807000.0 in Q4 2024, compared to $1.3 million in Q3 2024 and $800000.0 in Q2 2024.